# A Safety and Efficacy Study of Xyrem® in Subjects With Fibromyalgia

> **NCT00371137** · PHASE3 · COMPLETED · sponsor: **Jazz Pharmaceuticals** · enrollment: 548 (actual)

## Conditions studied

- Fibromyalgia

## Interventions

- **DRUG:** Xyrem®
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00371137
- **Lead sponsor:** Jazz Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2008-09
- **Final completion:** 2008-12
- **Target enrollment:** 548 (ACTUAL)
- **Last updated:** 2011-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00371137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00371137, "A Safety and Efficacy Study of Xyrem® in Subjects With Fibromyalgia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00371137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*